Back

Increased incidence of cancer metastasis in young patients with ischaemic heart disease

26 August 2023 (17:15 - 17:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular complications in patients with cancer Cardio-Oncology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tal Caller

Sheba Medical Center, Tel Aviv (Israel)

6 More presentations in this session

Presentation thumbnail
Major cardiovascular events in patients with atrial fibrillation and active lung cancer: data from the CANAC-FA registry, a multicentre, retrospective, observational study.
Doctor A. Piserra (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Vascular and neurological outcomes in patients with atrial fibrillation treated with edoxaban; effects of cancer
Assistant Professor K. Cheng (Kaohsiung, TW)
Abstract Slides
Presentation thumbnail
Chest pain in patients with cancer: prevalence of myocardial infarction and diagnostic performance of high-sensitivity cardiac troponin T/I
Doctor P. Bima (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Acute and long-term outcomes of acute coronary syndrome in patients with hematological malignancies
Doctor S. Lange (Munster, DE)
Abstract Slides Video
Presentation thumbnail
Characteristics and outcome of chest pain among patients with and without a history of cancer
Doctor K. Faierstein (Ramat Gan, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular complications in patients with cancer

The Event

Event poster

ESC Congress 2023

26 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of new cancer diagnosis following a NSTEMI event: insights from a national cancer registry
thumbnail
Congress Presentation
Cardiovascular outcomes, mortality, and bleeding in patients with acute myocardial infarction and a history of cancer: a report from the multi-center, nationwide prospective database JAMIR
thumbnail
Congress Presentation
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources